NCT04348370View on ClinicalTrials.gov

BCG Vaccine for Health Care Workers as Defense Against COVID 19

PHASE4CompletedINTERVENTIONAL
Enrollment

659

Participants

Timeline

Start Date

April 20, 2020

Primary Completion Date

April 21, 2023

Study Completion Date

April 21, 2023

Conditions
CoronavirusCoronavirus InfectionCoronavirus as the Cause of Diseases Classified Elsewhere
Interventions
BIOLOGICAL

BCG Vaccine

BCG vaccine will be administered by research nurses. Participants and investigators will be blinded.

BIOLOGICAL

Placebo Vaccine

Placebo vaccine will be administered by research nurses. Participants and investigators will be blinded.

Trial Locations (6)

77030

Baylor College of Medicine, Houston

Baylor St. Luke's Medical Center, Houston

Harris Health System - Ben Taub Hospital, Houston

MD Anderson Cancer Center, Houston

77802

Texas A&M Family Care Clinic, Bryan

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Cedars-Sinai Medical Center

OTHER

collaborator

Harvard University

OTHER

lead

Texas A&M University

OTHER

NCT04348370 - BCG Vaccine for Health Care Workers as Defense Against COVID 19 | Biotech Hunter | Biotech Hunter